세계의 임상 검사 서비스 시장 : 산업 분석, 시장 규모, 점유율, 성장, 동향 및 예측(2025-2035년)

Clinical Laboratory Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

US $ 5,795 ￦ 8,197,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795 ￦ 12,440,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795 ￦ 16,684,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

임상 검사 서비스 시장 - 분석 범위

TMR의 조사 보고서 "세계 임상 검사 서비스 시장"은 2025-2035년의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거와 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2025년을 기준 연도, 2035년을 예측 연도로 하여 2025년부터 2035년까지의 세계 임상 검사 서비스 시장의 매출과 예측을 제공합니다. 또한, 2025-2035년까지의 세계 임상 검사 서비스 시장의 연평균 성장률(CAGR%)을 제시합니다.

본 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도자료, 관련 문서 등을 참조하여 임상 검사 서비스 시장을 추론하였습니다.

시장 현황
시장 규모(2024년)	2,318억 달러
시장 규모(2035년)	3,621억 달러
CAGR	4.1%

이 보고서는 세계 임상 검사 서비스 시장 경쟁 구도를 조사했습니다. 세계 임상 검사 서비스 시장에서 사업을 운영하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT는 본 보고서에서 소개한 세계 임상 검사 서비스 시장의 기업 속성입니다.

세계 임상 실험실 서비스 시장 보고서가 답변한 주요 질문은 다음과 같습니다.

• 예측 기간 동안 모든 지역에서 아펠레시스의 매출/수익은?
• 세계 임상 검사 서비스 시장에서의 비즈니스 기회는?
• 시장의 주요 촉진요인, 시장 성장 억제요인, 기회, 위협 요인은 무엇인가? 예측 기간 동안 가장 빠른 CAGR로 성장할 지역 시장은 어디인가?
• 2035년 세계에서 가장 높은 수익을 창출할 것으로 예상되는 분야는?
• 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상되는 부문은?
• 세계 시장에서 사업을 전개하는 각 기업 시장 지위는?

임상 검사 서비스 시장 - 조사목적 및 조사방법

세계 임상 검사 서비스 시장에 대한 종합적인 보고서는 개요로 시작하여 연구 범위와 목적을 설명합니다. 본 조사의 목적, 시장에서 사업을 전개하고 있는 주요 벤더와 유통업체, 제품 승인에 관한 규제 시나리오에 대해 상세하게 설명합니다.

본 보고서는 가독성을 고려하여 각 섹션을 장별로 나누어 레이아웃을 구성하였습니다. 본 보고서는 그래프와 표를 적절히 배치한 종합적인 자료로 구성되어 있습니다. 주요 부문의 분석과 예측치를 도식화하여 독자에게 시각적으로 어필합니다. 또한, 과거와 예측 기간 말의 주요 부문별 시장 점유율을 비교할 수 있습니다.

본 보고서에서는 세계 임상 검사 서비스 시장을 검사 유형, 기술, 지역별로 분석합니다. 각 기준의 주요 부문을 상세하게 조사하고, 2035년 말 기준 각 부문 시장 점유율을 제공합니다. 이러한 귀중한 통찰력을 통해 시장 이해관계자들은 세계 임상 검사 서비스 시장에 대한 투자에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있습니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

• 서론
• 개요
• 시장 역학
• 세계의 임상 검사 서비스 시장 분석과 예측(2020-2035년)

제5장 주요 인사이트

• 주요 지역/국가 의료비 지출
• 주요 지역/국가 임상 검사 서비스 제공업체 리스트
• Porter의 Five Forces 분석
• PESTEL 분석
• 밸류체인 분석
• 최종사용자에 있어서의 주요 구입 지표
• 신규 시장 진출기업을 위한 시장 개척 전략
• 주요 업계 이벤트(파트너십, 협업, 제품 승인, 합병 및 인수)
• 주요 경쟁이 제공하는 서비스 벤치마킹

제6장 세계 시장 분석과 예측 : 검사 유형별

• 서론 및 정의
• 주요 분석 결과/진전
• 시장 예측(금액 기준) : 검사 유형별(2020-2035년)
  • 임상화학 검사
    • 정기화학 검사
    • 내분비 화학 검사
    • 치료제 모니터링 시험
    • 전문 화학 검사
    • 기타
  • 의료 미생물 검사
    • 감염증 검사
    • 이식 진단 검사
    • 기타
  • 혈액검사
    • 정기 혈액검사
    • 응고 검사
    • 전문 혈액검사
  • 면역학 검사
  • 유전자 검사
  • 세포 진찰 검사
  • 약물 남용 검사
  • 기타
• 시장의 매력 : 검사 유형별

제7장 세계 시장 분석과 예측 : 기술별

• 서론 및 정의
• 주요 분석 결과/진전
• 시장 예측(금액 기준) : 기술별(2020-2035년)
  • PCR
  • 질량분석
  • 차세대 시퀀싱
  • 면역측정
  • 크로마토그래피
  • POC(Point of Care) 검사
  • 기타
• 시장의 매력 : 기술별

제8장 세계 시장 분석과 예측 : 용도별

• 서론 및 정의
• 주요 분석 결과/진전
• 시장 예측(금액 기준) : 용도별(2020-2035년)
  • Drug Discovery & Development
  • 전임상 임상시험
  • 바이오 분석 및 실험실 화학
  • 독성 시험
  • 기타
• 시장의 매력 : 용도별

제9장 세계 시장 분석과 예측 : 서비스 제공업체별

• 서론 및 정의
• 주요 분석 결과/진전
• 시장 예측(금액 기준) : 서비스 제공업체별(2020-2035년)
  • 병원내 검사실
  • 독립 실험실
  • 클리닉내 검사실
• 시장의 매력 : 서비스 제공업체별

제10장 세계 시장 분석과 예측 : 지역별

• 주요 분석 결과
• 시장 예측(금액 기준) : : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 : 지역별

제11장 북미 시장 분석과 예측

• 미국
• 캐나다

제12장 유럽 시장 분석과 예측

• 독일
• 영국
• 프랑스
• 이탈리아
• 스페인
• 스위스
• 네덜란드
• 기타 유럽

제13장 아시아태평양 시장 분석과 예측

• 중국
• 인도
• 일본
• 한국
• 호주 및 뉴질랜드
• 기타 아시아태평양

제14장 라틴아메리카 시장 분석과 예측

• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카

제15장 중동 및 아프리카 시장 분석과 예측

• GCC 국가
• 남아프리카공화국
• 기타 중동 및 아프리카

제16장 경쟁 구도

• 시장 기업 - 경쟁 매트릭스(기업 Tier별, 규모별)
• 시장 점유율 분석 기업별(2024년)
• 기업 개요
  • Laboratory Corporation of America(LabCorp)
  • BioReference Health, LLC
  • PPD(Thermo Fisher Scientific Inc.)
  • Myriad Genetics, Inc.
  • NeoGenomics Laboratories.
  • Quest Diagnostics Incorporated
  • Siemens Healthcare Private Limited
  • Sonic Healthcare Limited
  • SYNLAB International GmbH
  • Eurofins Scientific
  • Charles River Laboratories
  • Mayo Clinic Laboratories
  • UNILABS
  • Metropolis Healthcare
  • H.U. Group Holdings, Inc.

LSH

영문 목차

영문목차

Clinical Laboratory Services Market- Scope of Report

TMR's report on the global Clinical Laboratory Services Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Clinical Laboratory Services Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Clinical Laboratory Services Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.

Market Snapshot
Market Value in 2024	US$ 231.8 Bn
Market Value in 2035	US$ 362.1 Bn
CAGR	4.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.

The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Clinical Laboratory Services Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Clinical Laboratory Services Marketprofiled in this report.

Key Questions Answered in Global Clinical Laboratory Services MarketReport:

• What is the sales/revenue generated by apheresis across all regions during the forecast period?
• What are the opportunities in the global two-wheeler navigation display market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Clinical Laboratory Services Market- Research Objectives and Research Approach

The comprehensive report on the global Clinical Laboratory Services Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Clinical Laboratory Services Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Clinical Laboratory Services Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Clinical Laboratory Services Market Analysis and Forecasts, 2020 to 2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Healthcare Expenditure across Key Regions / Countries
• 5.2. List of Clinical Laboratory Service Providers across Key Regions / Countries
• 5.3. PORTER's Five Forces Analysis
• 5.4. PESTEL Analysis
• 5.5. Value Chain Analysis
• 5.6. Key Purchase Metrics for End-users
• 5.7. Go-to-Market Strategy for New Market Entrants
• 5.8. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
• 5.9. Benchmarking of Services Offered by the Leading Competitors

6. Global Clinical Laboratory Services Market Analysis and Forecasts, By Test Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Test Type, 2020 to 2035
  • 6.3.1. Clinical Chemistry Testing
    • 6.3.1.1. Routine Chemistry Testing
    • 6.3.1.2. Endocrinology Chemistry Testing
    • 6.3.1.3. Therapeutic Drug Monitoring Testing
    • 6.3.1.4. Specialized Chemistry Testing
    • 6.3.1.5. Other Clinical Chemistry Testing
  • 6.3.2. Medical Microbiology Testing
    • 6.3.2.1. Infectious Disease Testing
    • 6.3.2.2. Transplant Diagnostic Testing
    • 6.3.2.3. Other Microbiology Testing
  • 6.3.3. Hematology Testing
    • 6.3.3.1. Routine Blood Testing
    • 6.3.3.2. Coagulation Testing
    • 6.3.3.3. Specialized Hematology Testing
  • 6.3.4. Immunology Testing
  • 6.3.5. Genetic Testing
  • 6.3.6. Cytology Testing
  • 6.3.7. Drug of Abuse Testing
  • 6.3.8. Others
• 6.4. Market Attractiveness By Test Type

7. Global Clinical Laboratory Services Market Analysis and Forecasts, By Technology

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Technology, 2020 to 2035
  • 7.3.1. PCR
  • 7.3.2. Mass Spectrometry
  • 7.3.3. Next-Generation Sequencing
  • 7.3.4. Immunoassay
  • 7.3.5. Chromatography
  • 7.3.6. Point-of-Care Testing
  • 7.3.7. Others
• 7.4. Market Attractiveness By Technology

8. Global Clinical Laboratory Services Market Analysis and Forecasts, By Application

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Application, 2020 to 2035
  • 8.3.1. Drug Discovery and Development
  • 8.3.2. Preclinical and Clinical Trial
  • 8.3.3. Bioanalytical and Lab Chemistry
  • 8.3.4. Toxicology Testing
  • 8.3.5. Others
• 8.4. Market Attractiveness By Application

9. Global Clinical Laboratory Services Market Analysis and Forecasts, By Type of Service Provider

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 9.3.1. Hospital-based Laboratories
  • 9.3.2. Standalone Laboratories
  • 9.3.3. Clinic-based Laboratories
• 9.4. Market Attractiveness By Type of Service Provider

10. Global Clinical Laboratory Services Market Analysis and Forecasts, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Region

11. North America Clinical Laboratory Services Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Test Type, 2020 to 2035
  • 11.2.1. Clinical Chemistry Testing
    • 11.2.1.1. Routine Chemistry Testing
    • 11.2.1.2. Endocrinology Chemistry Testing
    • 11.2.1.3. Therapeutic Drug Monitoring Testing
    • 11.2.1.4. Specialized Chemistry Testing
    • 11.2.1.5. Other Clinical Chemistry Testing
  • 11.2.2. Medical Microbiology Testing
    • 11.2.2.1. Infectious Disease Testing
    • 11.2.2.2. Transplant Diagnostic Testing
    • 11.2.2.3. Other Microbiology Testing
  • 11.2.3. Hematology Testing
    • 11.2.3.1. Routine Blood Testing
    • 11.2.3.2. Coagulation Testing
    • 11.2.3.3. Specialized Hematology Testing
  • 11.2.4. Immunology Testing
  • 11.2.5. Genetic Testing
  • 11.2.6. Cytology Testing
  • 11.2.7. Drug of Abuse Testing
  • 11.2.8. Others
• 11.3. Market Value Forecast By Technology, 2020 to 2035
  • 11.3.1. PCR
  • 11.3.2. Mass Spectrometry
  • 11.3.3. Next-Generation Sequencing
  • 11.3.4. Immunoassay
  • 11.3.5. Chromatography
  • 11.3.6. Point-of-Care Testing
  • 11.3.7. Others
• 11.4. Market Value Forecast By Application, 2020 to 2035
  • 11.4.1. Drug Discovery and Development
  • 11.4.2. Preclinical and Clinical Trial
  • 11.4.3. Bioanalytical and Lab Chemistry
  • 11.4.4. Toxicology Testing
  • 11.4.5. Others
• 11.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 11.5.1. Hospital-based Laboratories
  • 11.5.2. Standalone Laboratories
  • 11.5.3. Clinic-based Laboratories
• 11.6. Market Value Forecast By Country, 2020 to 2035
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Test Type
  • 11.7.2. By Technology
  • 11.7.3. By Application
  • 11.7.4. By Type of Service Provider
  • 11.7.5. By Country

12. Europe Clinical Laboratory Services Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Test Type, 2020 to 2035
  • 12.2.1. Clinical Chemistry Testing
    • 12.2.1.1. Routine Chemistry Testing
    • 12.2.1.2. Endocrinology Chemistry Testing
    • 12.2.1.3. Therapeutic Drug Monitoring Testing
    • 12.2.1.4. Specialized Chemistry Testing
    • 12.2.1.5. Other Clinical Chemistry Testing
  • 12.2.2. Medical Microbiology Testing
    • 12.2.2.1. Infectious Disease Testing
    • 12.2.2.2. Transplant Diagnostic Testing
    • 12.2.2.3. Other Microbiology Testing
  • 12.2.3. Hematology Testing
    • 12.2.3.1. Routine Blood Testing
    • 12.2.3.2. Coagulation Testing
    • 12.2.3.3. Specialized Hematology Testing
  • 12.2.4. Immunology Testing
  • 12.2.5. Genetic Testing
  • 12.2.6. Cytology Testing
  • 12.2.7. Drug of Abuse Testing
  • 12.2.8. Others
• 12.3. Market Value Forecast By Technology, 2020 to 2035
  • 12.3.1. PCR
  • 12.3.2. Mass Spectrometry
  • 12.3.3. Next-Generation Sequencing
  • 12.3.4. Immunoassay
  • 12.3.5. Chromatography
  • 12.3.6. Point-of-Care Testing
  • 12.3.7. Others
• 12.4. Market Value Forecast By Application, 2020 to 2035
  • 12.4.1. Drug Discovery and Development
  • 12.4.2. Preclinical and Clinical Trial
  • 12.4.3. Bioanalytical and Lab Chemistry
  • 12.4.4. Toxicology Testing
  • 12.4.5. Others
• 12.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 12.5.1. Hospital-based Laboratories
  • 12.5.2. Standalone Laboratories
  • 12.5.3. Clinic-based Laboratories
• 12.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 12.6.1. Germany
  • 12.6.2. UK
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Switzerland
  • 12.6.7. The Netherlands
  • 12.6.8. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Test Type
  • 12.7.2. By Technology
  • 12.7.3. By Application
  • 12.7.4. By Type of Service Provider
  • 12.7.5. By Country / Sub-region

13. Asia Pacific Clinical Laboratory Services Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Test Type, 2020 to 2035
  • 13.2.1. Clinical Chemistry Testing
    • 13.2.1.1. Routine Chemistry Testing
    • 13.2.1.2. Endocrinology Chemistry Testing
    • 13.2.1.3. Therapeutic Drug Monitoring Testing
    • 13.2.1.4. Specialized Chemistry Testing
    • 13.2.1.5. Other Clinical Chemistry Testing
  • 13.2.2. Medical Microbiology Testing
    • 13.2.2.1. Infectious Disease Testing
    • 13.2.2.2. Transplant Diagnostic Testing
    • 13.2.2.3. Other Microbiology Testing
  • 13.2.3. Hematology Testing
    • 13.2.3.1. Routine Blood Testing
    • 13.2.3.2. Coagulation Testing
    • 13.2.3.3. Specialized Hematology Testing
  • 13.2.4. Immunology Testing
  • 13.2.5. Genetic Testing
  • 13.2.6. Cytology Testing
  • 13.2.7. Drug of Abuse Testing
  • 13.2.8. Others
• 13.3. Market Value Forecast By Technology, 2020 to 2035
  • 13.3.1. PCR
  • 13.3.2. Mass Spectrometry
  • 13.3.3. Next-Generation Sequencing
  • 13.3.4. Immunoassay
  • 13.3.5. Chromatography
  • 13.3.6. Point-of-Care Testing
  • 13.3.7. Others
• 13.4. Market Value Forecast By Application, 2020 to 2035
  • 13.4.1. Drug Discovery and Development
  • 13.4.2. Preclinical and Clinical Trial
  • 13.4.3. Bioanalytical and Lab Chemistry
  • 13.4.4. Toxicology Testing
  • 13.4.5. Others
• 13.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 13.5.1. Hospital-based Laboratories
  • 13.5.2. Standalone Laboratories
  • 13.5.3. Clinic-based Laboratories
• 13.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 13.6.1. China
  • 13.6.2. India
  • 13.6.3. Japan
  • 13.6.4. South Korea
  • 13.6.5. Australia & New Zealand
  • 13.6.6. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Test Type
  • 13.7.2. By Technology
  • 13.7.3. By Application
  • 13.7.4. By Type of Service Provider
  • 13.7.5. By Country / Sub-region

14. Latin America Clinical Laboratory Services Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Test Type, 2020 to 2035
  • 14.2.1. Clinical Chemistry Testing
    • 14.2.1.1. Routine Chemistry Testing
    • 14.2.1.2. Endocrinology Chemistry Testing
    • 14.2.1.3. Therapeutic Drug Monitoring Testing
    • 14.2.1.4. Specialized Chemistry Testing
    • 14.2.1.5. Other Clinical Chemistry Testing
  • 14.2.2. Medical Microbiology Testing
    • 14.2.2.1. Infectious Disease Testing
    • 14.2.2.2. Transplant Diagnostic Testing
    • 14.2.2.3. Other Microbiology Testing
  • 14.2.3. Hematology Testing
    • 14.2.3.1. Routine Blood Testing
    • 14.2.3.2. Coagulation Testing
    • 14.2.3.3. Specialized Hematology Testing
  • 14.2.4. Immunology Testing
  • 14.2.5. Genetic Testing
  • 14.2.6. Cytology Testing
  • 14.2.7. Drug of Abuse Testing
  • 14.2.8. Others
• 14.3. Market Value Forecast By Technology, 2020 to 2035
  • 14.3.1. PCR
  • 14.3.2. Mass Spectrometry
  • 14.3.3. Next-Generation Sequencing
  • 14.3.4. Immunoassay
  • 14.3.5. Chromatography
  • 14.3.6. Point-of-Care Testing
  • 14.3.7. Others
• 14.4. Market Value Forecast By Application, 2020 to 2035
  • 14.4.1. Drug Discovery and Development
  • 14.4.2. Preclinical and Clinical Trial
  • 14.4.3. Bioanalytical and Lab Chemistry
  • 14.4.4. Toxicology Testing
  • 14.4.5. Others
• 14.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 14.5.1. Hospital-based Laboratories
  • 14.5.2. Standalone Laboratories
  • 14.5.3. Clinic-based Laboratories
• 14.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Argentina
  • 14.6.4. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Test Type
  • 14.7.2. By Technology
  • 14.7.3. By Application
  • 14.7.4. By Type of Service Provider
  • 14.7.5. By Country / Sub-region

15. Middle East & Africa Clinical Laboratory Services Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Test Type, 2020 to 2035
  • 15.2.1. Clinical Chemistry Testing
    • 15.2.1.1. Routine Chemistry Testing
    • 15.2.1.2. Endocrinology Chemistry Testing
    • 15.2.1.3. Therapeutic Drug Monitoring Testing
    • 15.2.1.4. Specialized Chemistry Testing
    • 15.2.1.5. Other Clinical Chemistry Testing
  • 15.2.2. Medical Microbiology Testing
    • 15.2.2.1. Infectious Disease Testing
    • 15.2.2.2. Transplant Diagnostic Testing
    • 15.2.2.3. Other Microbiology Testing
  • 15.2.3. Hematology Testing
    • 15.2.3.1. Routine Blood Testing
    • 15.2.3.2. Coagulation Testing
    • 15.2.3.3. Specialized Hematology Testing
  • 15.2.4. Immunology Testing
  • 15.2.5. Genetic Testing
  • 15.2.6. Cytology Testing
  • 15.2.7. Drug of Abuse Testing
  • 15.2.8. Others
• 15.3. Market Value Forecast By Technology, 2020 to 2035
  • 15.3.1. PCR
  • 15.3.2. Mass Spectrometry
  • 15.3.3. Next-Generation Sequencing
  • 15.3.4. Immunoassay
  • 15.3.5. Chromatography
  • 15.3.6. Point-of-Care Testing
  • 15.3.7. Others
• 15.4. Market Value Forecast By Application, 2020 to 2035
  • 15.4.1. Drug Discovery and Development
  • 15.4.2. Preclinical and Clinical Trial
  • 15.4.3. Bioanalytical and Lab Chemistry
  • 15.4.4. Toxicology Testing
  • 15.4.5. Others
• 15.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 15.5.1. Hospital-based Laboratories
  • 15.5.2. Standalone Laboratories
  • 15.5.3. Clinic-based Laboratories
• 15.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Test Type
  • 15.7.2. By Technology
  • 15.7.3. By Application
  • 15.7.4. By Type of Service Provider
  • 15.7.5. By Country / Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis By Company (2024)
• 16.3. Company Profiles
  • 16.3.1. Laboratory Corporation of America (LabCorp)
    • 16.3.1.1. Company Overview
    • 16.3.1.2. Financial Overview
    • 16.3.1.3. Product Portfolio
    • 16.3.1.4. Business Strategies
    • 16.3.1.5. Recent Developments
  • 16.3.2. BioReference Health, LLC
    • 16.3.2.1. Company Overview
    • 16.3.2.2. Financial Overview
    • 16.3.2.3. Product Portfolio
    • 16.3.2.4. Business Strategies
    • 16.3.2.5. Recent Developments
  • 16.3.3. PPD (Thermo Fisher Scientific Inc.)
    • 16.3.3.1. Company Overview
    • 16.3.3.2. Financial Overview
    • 16.3.3.3. Product Portfolio
    • 16.3.3.4. Business Strategies
    • 16.3.3.5. Recent Developments
  • 16.3.4. Myriad Genetics, Inc.
    • 16.3.4.1. Company Overview
    • 16.3.4.2. Financial Overview
    • 16.3.4.3. Product Portfolio
    • 16.3.4.4. Business Strategies
    • 16.3.4.5. Recent Developments
  • 16.3.5. NeoGenomics Laboratories.
    • 16.3.5.1. Company Overview
    • 16.3.5.2. Financial Overview
    • 16.3.5.3. Product Portfolio
    • 16.3.5.4. Business Strategies
    • 16.3.5.5. Recent Developments
  • 16.3.6. Quest Diagnostics Incorporated
    • 16.3.6.1. Company Overview
    • 16.3.6.2. Financial Overview
    • 16.3.6.3. Product Portfolio
    • 16.3.6.4. Business Strategies
    • 16.3.6.5. Recent Developments
  • 16.3.7. Siemens Healthcare Private Limited
    • 16.3.7.1. Company Overview
    • 16.3.7.2. Financial Overview
    • 16.3.7.3. Product Portfolio
    • 16.3.7.4. Business Strategies
    • 16.3.7.5. Recent Developments
  • 16.3.8. Sonic Healthcare Limited
    • 16.3.8.1. Company Overview
    • 16.3.8.2. Financial Overview
    • 16.3.8.3. Product Portfolio
    • 16.3.8.4. Business Strategies
    • 16.3.8.5. Recent Developments
  • 16.3.9. SYNLAB International GmbH
    • 16.3.9.1. Company Overview
    • 16.3.9.2. Financial Overview
    • 16.3.9.3. Product Portfolio
    • 16.3.9.4. Business Strategies
    • 16.3.9.5. Recent Developments
  • 16.3.10. Eurofins Scientific
    • 16.3.10.1. Company Overview
    • 16.3.10.2. Financial Overview
    • 16.3.10.3. Product Portfolio
    • 16.3.10.4. Business Strategies
    • 16.3.10.5. Recent Developments
  • 16.3.11. Charles River Laboratories
    • 16.3.11.1. Company Overview
    • 16.3.11.2. Financial Overview
    • 16.3.11.3. Product Portfolio
    • 16.3.11.4. Business Strategies
    • 16.3.11.5. Recent Developments
  • 16.3.12. Mayo Clinic Laboratories
    • 16.3.12.1. Company Overview
    • 16.3.12.2. Financial Overview
    • 16.3.12.3. Product Portfolio
    • 16.3.12.4. Business Strategies
    • 16.3.12.5. Recent Developments
  • 16.3.13. UNILABS
    • 16.3.13.1. Company Overview
    • 16.3.13.2. Financial Overview
    • 16.3.13.3. Product Portfolio
    • 16.3.13.4. Business Strategies
    • 16.3.13.5. Recent Developments
  • 16.3.14. Metropolis Healthcare
    • 16.3.14.1. Company Overview
    • 16.3.14.2. Financial Overview
    • 16.3.14.3. Product Portfolio
    • 16.3.14.4. Business Strategies
    • 16.3.14.5. Recent Developments
  • 16.3.15. H.U. Group Holdings, Inc.
    • 16.3.15.1. Company Overview
    • 16.3.15.2. Financial Overview
    • 16.3.15.3. Product Portfolio
    • 16.3.15.4. Business Strategies
    • 16.3.15.5. Recent Developments

관련자료